**Specification Table**TableSubject areaCancer ResearchMore specific subject areaSignal transduction AND Receptor Tyrosine KinasesType of dataWestern blot; qPCR, FACS, micro-array, Computational modelingHow data was acquiredFusion-FX7 chemiluminescence detection device (Vilber) for Western blotting,CLARIOstar microplate reader (BMG LABTECH) for fluorescence measurements of cell viabilityGeneChip Human Gene ST 2.0 arrays (Affymetrix) for micro-arrayFACS CantoII Instrument (Becton Dickinson, Heidelberg, Germany) for flow cytometryModel building and refinement with CHARMMExperimental featuresKIT and PDGFRA mutants were expressed in hek293 cell lines upon doxycycline additionExperiments were performed with/without ligand inductionData source locationLIH, Luxembourg and university of Luxembourg, LuxembourgData accessibilityData are available in the article, and at ArrayExpress E-MTAB-4548

**Value of the data**•Expression of different mutant proteins (Kit and PDGFRA) in an isogenic background to allow a direct comparison of their signalling capacities, without the complex patient specific- background. The constructs and/or the Hek293 cell lines, could be used for further molecular characterization, protein-protein interaction experiments or protein localization studies. Identified mutations in GIST could easily be investigated by insertion of the newly discovered mutation in the WT constructs by site-directed mutagenesis. Plasmids are available upon request.•Identification of a new feature specific to Kit mutants: their ability to be further stimulated by their natural ligand, in addition to their constitutive activation derived from the mutations observed in GIST.•A new MEK inhibitor (PD0325901) was identified to be efficient in inhibiting GIST cell proliferation in the nanomolar range.

1. Data {#s0005}
=======

The data presented here derived mainly from western blot analysis for the quantification of signaling pathways activated by KIT and PDGFRA mutants, from micro-array analysis for quantification of changes in gene expression levels induced by the different mutations and from flow cytometry analysis for the detection of KIT at the cell surface.

Doxycycline induces Kit expression by a factor 100 in all cell lines and comparable mRNA expression levels were observed for all mutants [(Fig. 1a)](#f0005){ref-type="fig"}. However, some differences in the protein expression levels were observed between the different constructs [(Fig. 1b)](#f0005){ref-type="fig"}.

The ratio of surface ([Fig. 1](#f0005){ref-type="fig"}a in [@bib1]) to total KIT expression ([Fig. 1](#f0005){ref-type="fig"}b in [@bib1]) indicates that KIT WT is expressed almost exclusively at the surface, while this is the case for 70% of KIT Ex9. This value drops to 50% for both Ex11 mutants. The results of the FACS analysis after SCF stimulation ([Fig. 2](#f0010){ref-type="fig"}) indicate the decrease of KIT expression at the cell surface for all KIT mutants and wild type following stimulation with KIT ligand, SCF.

The Mean Fluorescence Intensity (MFI) of Kit staining in the different Kit mutants are indicated in [Table 1](#t0005){ref-type="table"}.

While PDGFRα, Akt, and Erk phosphorylation were induced by PDGFAA in PDGFRaWT, phosphorylation of PDGFRα, Akt, Erk and STAT5 remained identical to the non-stimulated control for the PDGFRA mutant V591D, as previously shown [@bib3]. In contrast, Kit mutants exhibit all constitutive phosphorylation of kit at tyrosine 703 but the signal intensities for Erk, Akt and STAT5 phosphorylation was further increased upon SCF stimulation ([Fig. 3](#f0015){ref-type="fig"}a and [Fig. 3](#f0015){ref-type="fig"}b).

STATs translocation to the nucleus was identified for Kit Ex11 deletion mutant and for Kit Ex9 duplication mutant to a lower extend. Induction of gene expression known to be part of the STAT pathway was found for Kit Ex11 deletion mutant after SCF stimulation as well as for Kit Ex9 duplication mutant upon SCF stimulation to a lower extend ([Fig. 4](#f0020){ref-type="fig"}a and [Fig. 4](#f0020){ref-type="fig"}b).

We investigated KIT Ex11 specific gene signature, comparing KIT Exon 11 deletion mutant regulated genes to other GIST mutants (PDGFRA mutants and KIT Exon 9). 277 genes ([Table 3](#t0015){ref-type="table"}) were differentially expressed in KIT Ex11 deletion mutant only. As noted in [@bib1], these genes were associated with "cell cycle" and "insulin signalling pathway".

Both inhibitors were added to the medium 24 h after seeding for 30 h. Both drugs were added individually and in combination with a constant ratio of 1:1 ([Fig. 5](#f0025){ref-type="fig"}). Viability was assessed using PrestoBlue following the manufacturer׳s recommendation. Results were analysed using the Compusyn software [@bib5] and the combination Index (CI) values are represented as a function of the percentage of inhibition. CI values below 1 indicates a synergy between the two compounds, while CI values above 1 indicates antagonism.

GIST882 were treated with 100 nM imatinib for different times and mRNA expression level of ETV4, ETV5, egr1, FosL2 and FosB were assessed by qPCR. *n*= 3, Mean±SEM ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}, [Fig. 6](#f0030){ref-type="fig"}).

qPCR primers are listed in [Table 2](#t0010){ref-type="table"}.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Flow cytometry analysis {#s0015}
----------------------------

Cell surface expression of KIT wild type and mutants was analyzed by flow cytometry using a FACS CantoII Instrument (Becton Dickinson, Heidelberg, Germany) either without ligand (blue lines) or 15 minutesmin after stimulation with 100ng/ml100 ng/ml SCF (pink lines). Cells were then either incubated with 10 μL KIT primary antibody (anti-CD117-APC conjugated; C7244; Dako, Belgium) for cell surface expression. Specificity was controlled using an isotype-matched/ APC conjugated antibody (grey).

2.2. Western blot analysis {#s0016}
--------------------------

Cell lysis was performed on ice, using 1x Laemmli buffer. Proteins were subjected to SDS-PAGE, transferred to polyvinylidene difluoride membranes (Roth) and probed with primary antibodies. Primary antibodies against PLCγ and phosphospecific antibodies against STAT1 (pTyr701), STAT3 (pTyr705), ERK1/2 (pThr202/pTyr204), PDGFRA (pTyr849)/β(pTyr857), AKT (pSer473) and Mek1/2 were purchased from Cell Signalling Technology. Anti-STAT1 and anti-STAT3 antibodies and phosphospecific antibodies for STAT5 (pTyr694) and PLCγ1 (pTyr783) were obtained from BD Biosciences. Antibodies against STAT5 (C-17), PDGFRα (C-20), ERK1 (C-16), ERK2 (c-14), AKT1/2 (N-19) and tubulin (DM1A) were bought from Santa Cruz. Anti-CD117 (KIT) antibody was obtained from Dako and horseradish peroxidase-conjugated secondary antibodies from Cell Signalling Technology. Signals were detected on a Fusion-FX7 chemiluminescence detection device (Vilber) using a home-made ECL (Enhanced ChemiLuminescence) solution containing 2.5 mM luminol, 2.6 mM hydrogenperoxide, 100 mM Tris/HCl pH 8.8 and 0.2 mM para-coumaric acid [@bib6]. Signal intensities were quantified using the Bio1D analysis package (Vilber).

2.3. Microarray analysis {#s0020}
------------------------

293FR cells expressing KIT-WT, KIT Ex11 deletion mutant and KIT Ex9 mutant were incubated with 5 ng/ml doxycycline and 100 ng/ml SCF for 21 h in DMEM with 1%FCS. Cells were then starved for 3 h (without FCS) and further stimulated with SCF. RNAs of three biological replicates were isolated using the miRNeasy Mini KIT (Qiagen) according to manufacturer׳s instructions with additional on-column DNase I digestion. RNA quality and purity were assessed using a Nanodrop Spectrophotometer (Thermo Scientific) and Agilent 2100 Bioanalyzer (Nano KIT). Gene Expression analysis was performed using GeneChip Human Gene ST 2.0 arrays (Affymetrix). Quality control and data normalization were performed as previously reported [@bib3], [@bib7]. We focused on differentially expressed genes (DEG) across the mutants comparing with non-stimulated KIT-WT. To exclude non-relevant lowly expressed transcript clusters, only those showing log2 expression above 4.5 were kept for further analysis. Transcript clusters were further summarized in order to obtain a single expression value for each gene in each experiment. The differentially expressed genes were statistically evaluated by two-factor linear model with empirical Bayes statistics approach using limma package of R/Bioconductor [@bib8]. In order to correct for the false discovery rate (FDR), the Benjamini and Hochberg step-up method correction was applied. Probe-sets with FDR \<0.05 and absolute fold change \>0.5 were considered to be significantly differentially expressed (DEGs). Microarray data are available in the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-4548. KIT Ex11 specific gene signature was determined by comparing KIT Exon 11 deletion mutant regulated genes to other GIST mutants (PDGFRA mutants and KIT Exon 9). 277 genes.

2.4. Nuclear extract preparation {#s0025}
--------------------------------

Nuclear extracts were prepared as previously done [@bib4]. In brief, cells were washed with ice-cold PBS, harvested gently with cell scraper and centrifuged at 4 °C for 5 min, 4000 rpm. The pellet was then resuspend in Buffer A (10 mM Hepes/KOH pH7.9, 1.5 mM MgCl2 and 10 mM KCl). Following 10 min incubation on ice, samples were centrifuged at maximum speed, 4 °C for 5 min. The operation was performed a second time and the pellets were finally resuspended in Buffer C for nuclear extraction (20 mM Hepes/KOH pH7.9, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA and 25% glycerol). Protein concentrations were determined using Bradford reagent before analysis by western blotting.

2.5. Synergy analysis {#s0030}
---------------------

Synergy between Receptor Tyrosine kinase (RTK) and MEK inhibitors were performed at constant ratio, as recommended by Chou et al. [@bib5], [@bib9]. GIST primary cells were seeded in 96 well plates 24 h prior treatement. Inhibitors were added at concentration between 5 nM and 13 μM, either alone or in combination to a final volume of 90 μL. Endpoint viability was assessed using PrestoBlue (Thermofischer), by adding 10 μL of reagent to each well. Following 30 min incubation, fluorescence intensities were recorded on a CLARIOstar microplate reader (BMG LABTECH). Inhibition was then calculated as a ratio to the non-treated samples.

Transparency document. Supplementary material {#s0045}
=============================================
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![KIT RNA and protein expression levels in the stable transfected cells. (a) KIT mRNA expression level as assessed by qPCR in Hek293 cells expressing KIT WT, KIT Ex11, KIT Ex9 and KIT V559D 14 h after induction with doxycycline (5 ng/ml). SCF was added at 100 ng/ml for the time of induction. Data represent the means of 3--6 biological replicates and are normalized using Genorm following the MIQE guidelines [@bib2]. (b) Western blot analysis indicating KIT expression level as well as phosphorylation status in Hek293 cells expressing KIT WT, KIT Ex11, KIT Ex9 and KIT V559D 14 h after induction with doxycycline (5 ng/ml). SCF was added at 100 ng/ml for the time of induction or 5 min before cell harvesting as indicated on the figure. Representative data of 3 biological replicates. STAT5 is used as loading control.](gr1){#f0005}

![Effect of ligand stimulation on KIT expression at the cell surface.](gr2){#f0010}

###### 

Effect of ligand stimulation on downstream signaling in GIST mutants. (a) Western blot analysis indicating the phosphorylation status of KIT/PDGFRα, STAT5, Akt and Erk in Hek293 cells expressing PDGFRα WT, PDGFRα V561D, KIT WT, KIT Ex11, KIT Ex9 and KIT V559D after PDGFAA or SCF addition. Representative blots of 3 biological replicates. Tubulin is used as loading control. (b) Quantification of the signal intensities from the western blots shown in **a**. Data were calibrated using the sample "KIT WT non-stimulated" (background level), except for PDGFRA phosphorylation where PDGFRa WT non-stimulated was used. Each dot represents the mean of biological triplicates and the error bars the standard error of the mean. From left to right, bars represent the signal intensities after ligand addition (1st bars correspond to no ligand, 15 and 60 min after ligand addition are marked for better visibility).

Fig. 3:
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![](gr3b)

![Activation of STAT species by GIST mutants. (a) Nuclear translocation of STAT species. Nuclear extracts were prepared as previously done [@bib4], diluted in 4 times Laemmli buffer and subjected to Western blot analysis. Phosphorylation status of STAT5, STAT3 and STAT1 is shown for nuclear extract prepared from Hek293 cells expressing KIT WT, KIT Ex11, KIT Ex9 and KIT V559D. (b) Induction of known STAT target genes by GIST mutants. Gene expression level of known STAT target genes, previously identified to be induced in PDGFRA GIST mutants [@bib3], was retrieved from micro-array data and presented as heat map. Grey boxes indicate that the genes are not part of the DEG list for the corresponding mutant (FDR\>0.05 or AbsFC\<0.5). The intensity of the red color corresponds to the value of the ratio to the background (Hek293 KIT WT non-stimulated for KIT WT and mutants and Hek293 PDGFRα non-stimulated for PDGFRα mutants). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article) .](gr4){#f0020}

![Synergistic assessment for PD0325901 and XL184 inhibitors in GIST882.](gr5){#f0025}

![Imatinib effect on MAPK gene expression level over time.](gr6){#f0030}

###### 

Mean Fluorescence Intensity (MFI) of Kit staining in the different Kit mutants.

Table 1

  MFI                  Kit WT   Kit V559D   Kit Ex9   Kit ex11                        
  -------------------- -------- ----------- --------- ---------- ------ ------ ------ ------
                       −SCF     +SCF        −SCF      +SCF       −SCF   +SCF   −SCF   +SCF
                                                                                      
  Surface              2099     111         172       11         1435   284    562    222
  Overall expression   2122     642         374       319        2106   1355   1008   852

###### 

primers used for qPCR analysis.

Table 2

  --------------- ---------------------------
  Targeted gene   Primers sequences
  GAPDH           gtccttccacgataccaaagt
                  atgagaagtatgacaacagcct
                    
  HPRT            tggacaggactgaacgtctt
                  gagcacacagagggctacaa
                    
  PPIA/cycloA     cagacaaggtcccaaagaca
                  ccattatggcgtgtgaagtc
                    
  Tubulin         agatcggtgccaagttctg
                  ccacctgtggcttcattgta
                    
  ETV4            gcccctcgactctgaagat
                  tggaaatcaggaacaaactgc
                    
  ETV5            atccccgattatactttgacg
                  agaagggtgaccaggaactg
                    
  Kit             acaaagagcaaatccatccc
                  tgtaggtcagaatcatcacaataat
                    
  egr1            agtggtttggctggggtaa
                  ctacgagcacctgaccgc
                    
  sprty2          ttgcacatcgcagaaagaag
                  ggtcactccagcaggcttag
                    
  sprty4          gggagccactgagaacagag
                  tggctcctaaatccatcctg
  --------------- ---------------------------

###### 

KIT Ex11 deletion mutant specific DEG, with FDR\<0.05 and absolute logFC\>0.5.

Table 3

  ------------- ---------- ----------- -------------- ----------- ---------- ---------- ------------- -----------
  ACER2         CCNYL1     EYA1        IRX4           LOC401321   NKX3-1     RN5S217    SNORA10       UTRN
  ADAMTS20      CD109      FAHD1       ITGA2          LOC642838   NLRP1      RN5S335    SNORA16B      VRK3
  ADCK3         CD3EAP     FAM46A      JAM2           LOC645166   NOA1       RND2       SNORA2A       WDR63
  ADCY1         CD68       FAM47A      JMY            LPAL2       NR1D2      RNF167     SNORD111      WDR77
  AKAP8         CDC25B     FAM59A      KCNA3          LPCAT2      NRN1       RNFT1      SNORD126      WWP2
  ALDH1L2       CDT1       FAM64A      KDELR1         LPHN3       OLIG2      RNU2-7P    SNORD3C       ZC3H6
  ALG12         CES3       FAM83B      KDELR3         LPPR4       PABPC1L    RNU7-6P    SNORD60       ZFP14
  AMIGO2        CHEK2      FBXO32      KIAA0355       LRFN1       PAMR1      RPL13P5    SNORD71       ZNF140
  ANKRD18DP     CITED1     FLJ44342    KIAA1430       LURAP1L     PAQR4      RYR2       SNORD91A      ZNF17
  ANKRD20A12P   CKMT1A     FLJ45248    KIAA1609       LYSMD2      PARK2      SAMD15     SRCRB4D       ZNF239
  ANKRD20A5P    CNN2       FRAT2       KLF11          MALAT1      PARM1      SCARA5     TAS2R31       ZNF280B
  ANKRD27       CNTNAP3B   GALNT6      KLHL24         MCL1        PARP14     SCARNA21   TBX15         ZNF296
  ARHGAP20      CPEB4      GGA2        KLHL36         MCM5        PARP4      SEMA6A     TCF25         ZNF347
  ARHGAP35      CPPED1     GLTSCR2     KLRAP1         MDM2        PBX1       SERPINB1   TFAP4         ZNF485
  ARHGEF1       CRKL       GRAMD4      LCMT1          MED12L      PCDH7      SGK1       THOC6         ZNF502
  ARNT2         CRYBB2P1   GSPT2       LIG4           MGARP       PDP1       SGSM3      TIGD4         ZNF574
  ASRGL1        CSDA       GYPC        LIN37          MGST1       PDPR       SHKBP1     TMEM143       ZNF581
  BACE1-AS      CYP2S1     GYS1        LINC00282      MIR22HG     PHKB       SHMT2      TMEM159       ZNF70
  BBIP1         CYP4×1     H2BFXP      LNP1           MIR3143     PKIA       SLC35B2    TMEM185B      ZNF738
  BCL6          DDTL       HIST1H2BG   LOC100130776   MIR338      PLA2G7     SLC44A2    TMEM238       ZNF836
  BEX5          DEDD2      HIST1H3A    LOC100132439   MIR3671     PLXNA2     SLC45A3    TNFRSF10D     ZSCAN12P1
  BRD2-IT1      DLC1       HIST1H3H    LOC100133985   MIR4263     PMFBP1     SLC6A6     TNFRSF13C     
  BZW1          DMRTA1     HLA-DRB5    LOC100272228   MIR4324     PPP1R13L   SLC7A6OS   TNRC6B        
  C10orf10      DYNLL2     HSDL1       LOC100287628   MIR4530     PPP1R14C   SLC8A1     TOM1          
  C10orf25      EBF3       IER5        LOC100288018   MIR4773-2   PROX1      SLC9A1     TP53I13       
  C19orf54      ECH1       IFITM3      LOC100288520   MIR548A2    PRPH       SLC9A2     TRBV23OR9-2   
  C22orf13      EID3       IGHD2-21    LOC100507299   MRI1        PRR12      SLC9A9     TRBV6-9       
  C2orf77       EIF1       IL11        LOC147670      MTRF1L      PSEN2      SMOC1      TRPC1         
  CABIN1        ELAC1      ILDR2       LOC147727      MTSS1       RAB39B     SMPD1      TRPS1         
  CABLES1       EMR2       IMPA2       LOC284648      NFIX        RBL2       SNAR-D     TSC2          
  CAMLG         EPHX4      INPP5D      LOC399815      NIPSNAP1    RHBDF1     SNAR-H     TSSK3         
  CAP2          EPS15L1    IQCH        LOC400927      NIPSNAP3A   RN5S180    SNN        TXNDC17       
  ------------- ---------- ----------- -------------- ----------- ---------- ---------- ------------- -----------
